ProAssurance downgraded at SunTrust

theflyonthewall.com

As previously reported, SunTrust downgraded ProAssurance to Neutral from Buy. The firm downgraded shares due increasing price competition and changing physician buying patterns that is pressuring medical malpractice segment returns. Price target lowered to $52 from $58.

View Comments (0)